SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA crypto token is currently trending amidst intense community scrutiny and debate, with many investors labeling it a pump-and-dump scheme following its significant decline from earlier highs. Discussions are heavily polarized, featuring widespread accusations of a grift by those frustrated with its performance, while a vocal minority of supporters maintain speculative interest ahead of a promotional documentary release.

Exchange Traded Concepts Trust - ROBO Global Robotics and Automation Index ETF

Exchange Traded Concepts Trust - ETCT ROBO Global Robotics and Automation Index ETF

ROBO is reaching new all-time highs as the robotics and automation sector gains momentum from strong demand for labor-saving technology, leading many in the community to label it a core long-term investment. Investors are actively discussing the integration of humanoid robotics and AI, with many choosing this ETF to gain diversified exposure to the secular growth of the machine era.

Global X Funds - Global X Funds Global X Robotics & Artificial Intelligence ETF

Global X Funds Global X Robotics & Artificial Intelligence ETF

Investors are actively weighing the long-term potential of the robotics and AI sector, with community discussion focused on its role in addressing labor shortages and industrial automation. Sentiment is split between those viewing the ETF as a strategic play on rapid technological adoption and others concerned about market volatility and current valuations.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is experiencing renewed momentum driven by its integration into the AI narrative and significant growth in active user metrics. The community is actively debating its long-term potential as an infrastructure layer, with many participants focused on staking strategies and accumulating during periods of volatility.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is currently trending as investors focus on its dominance as a leading decentralized perpetual exchange, with significant community attention directed toward its transaction volume and institutional interest. Discussions are heavily focused on the stock's role as high-speed financial infrastructure, with many traders closely watching support levels as the community debates whether current volatility represents a consolidation phase or a precursor to further parabolic growth.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating intense debate as traders weigh its historically low circulating supply against concerns over long-term project viability. While proponents argue that its limited supply makes it primed for a significant breakout, skeptics warn that the token has seen persistent declines and lacks the momentum of top-tier assets.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

The Avalanche community is expressing intense frustration and exhaustion as the token hits new multi-year lows, fueling debates over whether the current price represents a capitulation bottom or a sign of terminal decline. Despite new institutional catalysts like the launch of a spot ETF and ongoing real-world asset tokenization, investors remain deeply skeptical, with many focusing on deep-averaging strategies while others abandon the asset for Bitcoin.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

Core Scientific is seeing significant interest as it accelerates its pivot from Bitcoin mining to high-performance computing infrastructure, supported by a massive power pipeline and hyperscale contracts. The community is actively debating the company's execution timeline and its ability to secure new anchor tenants following recent capital raises and management's strategic focus on the AI-energy bottleneck.

BitGo Holdings, Inc. provides cryptocurrency custody solutions. It offers self-custody wallet, qualified custody, liquidity and prime, and infrastructure-as-a-service. The company was founded by Michael Belshe in 2013 and is headquartered in Palo Alto, CA.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo Holdings (BTGO) is trending amid intense investor debate following its recent IPO, with community members polarized between those viewing current price levels as a generational buying opportunity and others highlighting risks associated with its transition to a federally chartered bank model. While some investors are actively accumulating shares and pointing to institutional growth, significant conversation centers on the stock's volatile price action and ongoing legal disputes impacting sentiment.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUI is generating significant community buzz following the elimination of gas fees for transfers on its mainnet, a development seen as a major catalyst for stablecoin adoption. Traders are actively debating the token's technical positioning near resistance levels, with many focusing on its potential for long-term growth and its ability to attract institutional interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

S&P 500 Clocks Best Weekly Rally Since 2023, Dow Hits Fresh Record As US-Iran Peace Hope Boosts Risk Sentiment - UBER, GILD, RDDT, FJET, AMD In Focus

Equity

IPO optimism, robust corporate earnings, and a $2 billion quantum computing push aided U.S. stock indices this week.

GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment 

 U.S. Food and Drug Administration (FDA) approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus.

FDA Grants Accelerated Approval to Gileads Hepcludex (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex (bulevirtide-gmod) 8.5 mg for the treatment of adults living with chronic hepatitis delta virus (HDV) infection, making it the first and only approved...

Gilead Receives CHMP Positive Opinion for Trodelvy in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the marketing authorization of Trodelvy (sacituzumab govitecan-hziy) as a monotherapy for the...

New ASCO and EHA 2026 Data Demonstrate Gilead and Kites Momentum Across Antibody-Drug Conjugates and Cell Therapy in Oncology

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that together with Kite, a Gilead company, it will present more than 25 abstracts, including six oral presentations, at the 2026 ASCO Annual Meeting (May 29 June 2) and the 2026 EHA Congress (June 11 14). These presentations underscore the...

Top Analyst Reports for Applied Materials, Shell & KLA

AMAT, SHEL and KLAC lead Zacks' top analyst reports as AI demand, LNG growth and advanced packaging fuel momentum.

Gilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfolio

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of its previously announced acquisition of Tubulis GmbH, a private Germany-based, clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs). The acquisition brings Gilead...

Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis, a Fatal Parasitic Disease

Gilead Sciences, Inc. (Nasdaq: GILD) today announced a renewed five-year collaboration with the World Health Organization (WHO), committing funding, strategic support and product donations to accelerate progress toward eliminating visceral leishmaniasis (VL), also known as kala-azar. VL, the second...

Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Morgan Stanley Reassesses Gilead Sciences (GILD) Outlook Following Quarterly Report

Morgan Stanley Reassesses Gilead Sciences (GILD) Outlook Following Quarterly Report...

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Current Price	$134.36
Prev Close	$130.50
Open	$131.57
Dividend Yield	2.57%
50-Day Moving Average	$135.86
Beta	0.37
Avg. Volume	5.31M
PE Ratio	18.28

52-Week High	$157.29
52-Week Low	$104.46
Market Capitalization	$166.82B
EPS (Annual)	$6.78
Price to Book	7.10
Revenue Per Employee	$1.73M

GILD
Gilead Sciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest GILD News

GILDGilead Sciences, Inc.